Factors influencing the production of cardiomyopathies by methoxamine and metaraminol.
D000315:Adrenalectomy; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001014:Aortic Aneurysm / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D004032:Diet; D004487:Edema / Q000139:chemically induced; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced*; D006830:Hydralazine / Q000494:pharmacology; D006984:Hypertrophy / Q000139:chemically induced; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D007668:Kidney / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008680:Metaraminol / Q000037:antagonists & inhibitors; D008729:Methoxamine / Q000037:antagonists & inhibitors; D009336:Necrosis / Q000139:chemically induced; D011188:Potassium; D051381:Rats; D012964:Sodium; D013566:Sympathomimetics / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D013566:Sympathomimetics; D006830:Hydralazine; D008680:Metaraminol; D012964:Sodium; D008729:Methoxamine; D007545:Isoproterenol; D011188:Potassium